Nomura Holdings
FATE icon

Nomura Holdings’s Fate Therapeutics FATE Stock Holding History

Nomura Holdings’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-381,770
Closed -$3.85M – 1546
2022
Q4 		$3.85M Buy
381,770
+230,554
+152% +$4.33M 0.02% 562
2022
Q3 		$3.41M Buy
151,216
+114,967
+317% +$3.32M 0.01% 671
2022
Q2 		$909K Buy
+36,249
New +$1M ﹤0.01% 986
2021
Q3 		– Sell
-2,570
Closed -$224K – 2058
2021
Q2 		$224K Sell
2,570
-6,430
-71% -$518K ﹤0.01% 1711
2021
Q1 		$741K Buy
+9,000
New +$862K ﹤0.01% 1211
2016
Q1 		– Sell
-13,000
Closed -$44K – 1688
2015
Q4 		$44K Buy
+13,000
New +$54.6K ﹤0.01% 1768

Other funds holding FATE

State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Nomura Holdings's FATE Position: Q1 2023 in Review

Nomura Holdings sold out of Fate Therapeutics (FATE) in Q1 2023, closing a stake of 381,770 shares — an estimated $3.85M sold.

Nomura Holdings first reported a position in FATE in Q4 2015 and held it in 6 quarters. The position peaked at $3.85M in Q4 2022. 181 funds tracked by Wall St. Rank hold FATE as of Q1 2023.

  • Nomura Holdings reported no remaining Fate Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Nomura Holdings sold 381,770 Fate Therapeutics shares in Q1 2023, an estimated $3.85M.
  • Nomura Holdings first reported a position in Fate Therapeutics in Q4 2015 and held it in 6 quarters.
  • Nomura Holdings's Fate Therapeutics position peaked at $3.85M in Q4 2022.
  • 181 funds tracked by Wall St. Rank held Fate Therapeutics as of Q1 2023.

Based on Nomura Holdings's 13F filing for Q1 2023, filed 15 May 2023.